Literature DB >> 26679999

Type I Interferon Signaling Is Decoupled from Specific Receptor Orientation through Lenient Requirements of the Transmembrane Domain.

Nanaocha Sharma1, Geeta Longjam1, Gideon Schreiber2.   

Abstract

Type I interferons serve as the first line of defense against pathogen invasion. Binding of IFNs to its receptors, IFNAR1 and IFNAR2, is leading to activation of the IFN response. To determine whether structural perturbations observed during binding are propagated to the cytoplasmic domain, multiple mutations were introduced into the transmembrane helix and its surroundings. Insertion of one to five alanine residues near either the N or C terminus of the transmembrane domain (TMD) likely promotes a rotation of 100° and a translation of 1.5 Å per added residue. Surprisingly, the added alanines had little effect on the binding affinity of IFN to the cell surface receptors, STAT phosphorylation, or gene induction. Similarly, substitution of the juxtamembrane residues of the TMD with alanines, or replacement of the TMD of IFNAR1 with that of IFNAR2, did not affect IFN binding or activity. Finally, only the addition of 10 serine residues (but not 2 or 4) between the extracellular domain of IFNAR1 and the TMD had some effect on signaling. Bioinformatic analysis shows a correlation between high sequence conservation of TMDs of cytokine receptors and the ability to transmit structural signals. Sequence conservation near the TMD of IFNAR1 is low, suggesting limited functional importance for this region. Our results suggest that IFN binding to the extracellular domains of IFNAR1 and IFNAR2 promotes proximity between the intracellular domains and that differential signaling is a function of duration of activation and affinity of binding rather than specific conformational changes transmitted from the outside to the inside of the cell.
© 2016 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  cell signaling; cytokine receptor; interferon; mutagenesis; protein-protein interaction; transmembrane domain

Mesh:

Substances:

Year:  2015        PMID: 26679999      PMCID: PMC4751381          DOI: 10.1074/jbc.M115.686071

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  64 in total

1.  The single transmembrane domains of ErbB receptors self-associate in cell membranes.

Authors:  Jeannine M Mendrola; Mitchell B Berger; Megan C King; Mark A Lemmon
Journal:  J Biol Chem       Date:  2001-12-10       Impact factor: 5.157

2.  Seeing the light: preassembly and ligand-induced changes of the interferon gamma receptor complex in cells.

Authors:  Christopher D Krause; Erwen Mei; Junxia Xie; Yiwei Jia; Martin A Bopp; Robin M Hochstrasser; Sidney Pestka
Journal:  Mol Cell Proteomics       Date:  2002-10       Impact factor: 5.911

3.  A null mutation in the gene encoding a type I interferon receptor component eliminates antiproliferative and antiviral responses to interferons alpha and beta and alters macrophage responses.

Authors:  S Y Hwang; P J Hertzog; K A Holland; S H Sumarsono; M J Tymms; J A Hamilton; G Whitty; I Bertoncello; I Kola
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-21       Impact factor: 11.205

4.  Active and inactive orientations of the transmembrane and cytosolic domains of the erythropoietin receptor dimer.

Authors:  Nadine Seubert; Yohan Royer; Judith Staerk; Katharina F Kubatzky; Virginie Moucadel; Shyam Krishnakumar; Steven O Smith; Stefan N Constantinescu
Journal:  Mol Cell       Date:  2003-11       Impact factor: 17.970

5.  Dimerization of the extracellular domain of the human growth hormone receptor by a single hormone molecule.

Authors:  B C Cunningham; M Ultsch; A M De Vos; M G Mulkerrin; K R Clauser; J A Wells
Journal:  Science       Date:  1991-11-08       Impact factor: 47.728

6.  Phosphorylated interferon-alpha receptor 1 subunit (IFNaR1) acts as a docking site for the latent form of the 113 kDa STAT2 protein.

Authors:  H Yan; K Krishnan; A C Greenlund; S Gupta; J T Lim; R D Schreiber; C W Schindler; J J Krolewski
Journal:  EMBO J       Date:  1996-03-01       Impact factor: 11.598

7.  Role of STAT2 in the alpha interferon signaling pathway.

Authors:  S Leung; S A Qureshi; I M Kerr; J E Darnell; G R Stark
Journal:  Mol Cell Biol       Date:  1995-03       Impact factor: 4.272

8.  Ligand-induced association of the type I interferon receptor components.

Authors:  B Cohen; D Novick; S Barak; M Rubinstein
Journal:  Mol Cell Biol       Date:  1995-08       Impact factor: 4.272

9.  The TOPCONS web server for consensus prediction of membrane protein topology and signal peptides.

Authors:  Konstantinos D Tsirigos; Christoph Peters; Nanjiang Shu; Lukas Käll; Arne Elofsson
Journal:  Nucleic Acids Res       Date:  2015-05-12       Impact factor: 16.971

10.  Differential tyrosine phosphorylation of the IFNAR chain of the type I interferon receptor and of an associated surface protein in response to IFN-alpha and IFN-beta.

Authors:  C Abramovich; L M Shulman; E Ratovitski; S Harroch; M Tovey; P Eid; M Revel
Journal:  EMBO J       Date:  1994-12-15       Impact factor: 11.598

View more
  9 in total

Review 1.  The molecular basis for differential type I interferon signaling.

Authors:  Gideon Schreiber
Journal:  J Biol Chem       Date:  2017-03-13       Impact factor: 5.157

2.  Kinetics of cytokine receptor trafficking determine signaling and functional selectivity.

Authors:  Jonathan Martinez-Fabregas; Stephan Wilmes; Luopin Wang; Majid Kazemian; Suman Mitra; Ignacio Moraga; Maximillian Hafer; Elizabeth Pohler; Juliane Lokau; Christoph Garbers; Adeline Cozzani; Paul K Fyfe; Jacob Piehler
Journal:  Elife       Date:  2019-11-27       Impact factor: 8.140

3.  A hot spot on interferon α/β receptor subunit 1 (IFNAR1) underpins its interaction with interferon-β and dictates signaling.

Authors:  Nicole A de Weerd; Antony Y Matthews; Phillip R Pattie; Nollaig M Bourke; San S Lim; Julian P Vivian; Jamie Rossjohn; Paul J Hertzog
Journal:  J Biol Chem       Date:  2017-03-13       Impact factor: 5.157

4.  Dynamic Modulation of Binding Affinity as a Mechanism for Regulating Interferon Signaling.

Authors:  Hongchun Li; Nanaocha Sharma; Ignacio J General; Gideon Schreiber; Ivet Bahar
Journal:  J Mol Biol       Date:  2017-06-23       Impact factor: 5.469

5.  Facile discovery of surrogate cytokine agonists.

Authors:  Michelle Yen; Junming Ren; Qingxiang Liu; Caleb R Glassman; Timothy P Sheahan; Lora K Picton; Fernando R Moreira; Arjun Rustagi; Kevin M Jude; Xiang Zhao; Catherine A Blish; Ralph S Baric; Leon L Su; K Christopher Garcia
Journal:  Cell       Date:  2022-03-23       Impact factor: 66.850

6.  A Glycoengineered Interferon-β Mutein (R27T) Generates Prolonged Signaling by an Altered Receptor-Binding Kinetics.

Authors:  Saehyung Lee; Woo Sung Son; Ho Bin Yang; Nirmal Rajasekaran; Sung-Su Kim; Sungyoul Hong; Joon-Seok Choi; Jun Young Choi; Kyoung Song; Young Kee Shin
Journal:  Front Pharmacol       Date:  2019-01-24       Impact factor: 5.810

Review 7.  The Role of Structure in the Biology of Interferon Signaling.

Authors:  Mark R Walter
Journal:  Front Immunol       Date:  2020-11-12       Impact factor: 7.561

Review 8.  Shared and Unique Features of Human Interferon-Beta and Interferon-Alpha Subtypes.

Authors:  Megen C Wittling; Shannon R Cahalan; Eric A Levenson; Ronald L Rabin
Journal:  Front Immunol       Date:  2021-01-19       Impact factor: 7.561

Review 9.  The Role of Type I Interferons in the Pathogenesis and Treatment of COVID-19.

Authors:  Gideon Schreiber
Journal:  Front Immunol       Date:  2020-09-30       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.